Document is current
Any future updates will be listed below
-
Authors
Taylor, David https://orcid.org/0000-0002-2557-1710
- License Information
-
More Information
Article History
Received: 10 September 2025
Accepted: 26 September 2025
First Online: 17 December 2025
Competing interests
: D.T. has received investigator-initiated research grants from Janssen; received speaker fees from Lundbeck, Otsuka, Viatris and Recordati; and has shares in Myogenes, Saladax and 428-Pharma.
